MedTrace Logo

Effects of Dual-Task Training on Upper Extremity Function in Parkinson's Disease

NCT07536542 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2026-04-17

No results posted yet for this study

Summary

The goal of this clinical trial is to investigate the effects of dual-task training on upper extremity function and muscle thickness in individuals with Parkinson's disease. The main questions it aims to answer are:

Does dual-task training improve upper extremity function in individuals with Parkinson's disease? Does dual-task training lead to changes in upper extremity muscle thickness measured by ultrasonography?

Researchers will compare a dual-task training group with a control group receiving routine care to determine whether 8 weeks of dual-task training results in greater improvements in upper extremity outco

Participants will:

complete baseline and post-intervention assessments of upper extremity function, muscle thickness, grip strength, and pinch strength be assigned to either a control group or a dual-task training group receive dual-task training 3 days per week for 8 weeks if assigned to the intervention group

Conditions

  • Parkinson Disease (PD)

Interventions

BEHAVIORAL

Dual-Task Training

Dual-task training will be applied 3 times per week for 8 weeks, with each session lasting 60 minutes. The program combines motor tasks (such as peg placement, object manipulation, bilateral coordination, and mobility tasks) with simultaneous cognitive tasks (such as backward counting, category-based word generation, and memory tasks).

Sponsors & Collaborators

  • Hacettepe University

    collaborator OTHER

  • Ankara University

    lead OTHER

Principal Investigators

  • Büşra Seçkinoğulları Korkusuz · Ankara University

  • Süleyman Korkusuz · Atılım University

  • Ayşenur Özcan · Çankırı Karatekin University

  • Ayla Fil · Hacettepe University

  • Gül Yalçın Çakmaklı · Hacettepe University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-24
Primary Completion
2026-07-24
Completion
2026-08-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07536542 on ClinicalTrials.gov